The American Journal of Managed Care2d
FDA Approves Zanidatamab-hrii for HER2+ Biliary Tract Cancer
Currently, chemotherapy remains a common treatment for biliary tract cancers, which have a limited survival rate.
mskcc.org2d
FDA Approves Zanidatamab for Biliary Tract Cancers With High HER2 Levels
Learn more about a new treatment for biliary tract cancers with high levels of HER2. The drug zanidatamab has been approved ...
FiercePharma2d
Jazz's HER2 bispecific snags FDA nod, teeing up showdown with AZ and Daiichi's Enhertu
The new drug, Jazz Pharmaceuticals’ zanidatamab, has won an FDA accelerated approval for adults with previously treated ...
Jazz and Zymeworks announce FDA approval of cancer therapy Ziihera
Jazz Pharmaceuticals (JAZZ) stock and Zymeworks (ZYME) stock gain as FDA clears their cancer therapy Ziihera. Read more here.
Jazz Pharma Gains FDA Accelerated Approval For Ziihera To Treat HER2-positive Biliary Tract Cancer
Jazz Pharmaceuticals plc (JAZZ) announced the U.S. Food and Drug Administration accelerated approval of Ziihera (zanidatamab-hrii) ...
FDA Approves UCB's Psoriasis Drug For Expanded Use In Painful Inflammatory Skin Disease
FDA approves UCB's Bimzelx for adults with moderate to severe hidradenitis suppurativa, supported by Phase 3 trials showing significant symptom improvement.
The American Journal of Managed Care3d
FDA Approves Bimekizumab in Hidradenitis Suppurativa
This approval is the fifth overall for bimekizumab (Bimzelyx; UCB Pharma) in the US, and they all have come in the last 13 ...